A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
Clinical trial NCT06630429 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06630429
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-02
- Primary completion
- 2026-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.